Numerous evidences have confirmed that IGF-1R was a promising target for cancer therapy [19,34], which was overexpressed in colorectal cancer (CRC), and mediated anti-apoptosis activity in CRC development [24,35]. Here, IGF1R is linked to colorectal carcinoma.